Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank57
3Y CAGR-30.5%
5Y CAGR-21.8%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-30.5%/yr
Annual compound
5Y CAGR
-21.8%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.10 | -71.6% |
| 2024 | 0.37 | -29.2% |
| 2023 | 0.52 | +67.0% |
| 2022 | 0.31 | +69.4% |
| 2021 | 0.18 | -48.4% |
| 2020 | 0.35 | +43.9% |
| 2019 | 0.25 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.00 | -94.6% |
| 2016 | 0.04 | - |